Human papillomavirus vaccines in Picardy, France: Coverage and correlation with socioeconomic factors

Ganry, O.; Bernin-Mereau, A.-S.; Gignon, Maxime; Merlin-Brochard, J.; Schmit, Jean‐Luc

doi:10.1016/j.respe.2013.04.005

Cited by 15 publications

(18 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Overall, data on 6,247,077 women aged from 12 to 44 years were included in the studies presented in 23 articles, representing ten countries. Of the included studies, 11 focused on the HPVV initiation ( 10 , 12 – 14 , 18 , 19 , 21 – 23 , 28 , 31 ) and factors associated with it, three focused on HPVV completion ( 11 , 25 , 27 ), and nine focused on both initiation and completion ( 15 – 17 , 20 , 24 , 26 , 29 , 30 , 32 ), along with factors associated with it. Sample size ranged from 238 to 2,493,698 women, and 19 studies had a sample size over 1,000.…”

Section: Resultsmentioning

confidence: 99%

“…For two of these studies ( 22 , 24 ), however, this association was only seen for those girls that belong to the catch-up group (17–18 and 14–16 years, respectively). On the contrary, three studies ( 17 , 20 , 31 ) found no evidence of association between HPVV initiation and socio-economic status. Regarding education level as such, a small study ( 19 ) found that girls with more than 11 years of school education had a higher HPVV initiation than those with less than 11 years of education.…”

Section: Factors Associated With Vaccine Initiationmentioning

confidence: 86%

“…Overall, 12 studies ( 10 , 12 , 17 , 19 – 24 , 28 , 31 , 32 ) compared HPVV initiation by ethnicity. Nine ( 10 , 12 , 17 , 20 – 24 , 32 ) found an association between ethnicity and HPVV initiation, where the uptake was substantially lower in areas with high ethnic minority populations. Out of the nine, three studies ( 20 , 23 , 24 ) conducted in the UK showed that the probability of Non-white girls being vaccinated was lower compared to White girls.…”

Section: Factors Associated With Vaccine Initiationmentioning

confidence: 99%

“…Fourteen articles ( 10 , 13 – 15 , 17 , 20 – 24 , 26 , 29 , 31 , 32 ) reported data on socio-economic status or area-level indicators and HPV vaccine initiation. All studies ( 10 , 13 – 15 , 21 – 24 , 26 , 29 , 32 ) but three ( 17 , 20 , 31 ) showed an association between pertaining to a disadvantaged socio-economic group and lower HPVV initiation. For two of these studies ( 22 , 24 ), however, this association was only seen for those girls that belong to the catch-up group (17–18 and 14–16 years, respectively).…”

Section: Factors Associated With Vaccine Initiationmentioning

confidence: 99%

See 3 more Smart Citations

Determinants in the Uptake of the Human Papillomavirus Vaccine: A Systematic Review Based on European Studies

2015

View full text Add to dashboard Cite

BackgroundCervical cancer is the fourth most common cancer affecting women worldwide. Since 2006, two human papillomavirus vaccines (HPVV) have been licensed to protect women against the virus that causes cervical cancer. However, worldwide coverage remains unequal. Studies from the USA found strong evidence for differences in HPVV uptake by ethnicity and healthcare coverage. As the profile of ethnic groups and the healthcare system in the USA differ from countries in Europe where HPVV is free in most of the countries, we conducted a systematic review in order to analyze the determinants of HPVV uptake in Europe.MethodsWe performed a systematic Pubmed, Scopus, and Science Direct search to find articles published from HPVV availability in European countries until April 2014. No age restriction was applied. We included all studies assessing factors associated with HPVV uptake. Uptake refers to either initiation and/or completion of the three dose vaccination program.ResultsOut of the 23 eligible studies, 14 were retrospective reviews of data, six were cross-sectional surveys, and three were prospective cohort studies. Higher HPVV uptake was associated with ethnic majority populations, higher socio-economic status, regular cervical screening participation by the mother, and having received previous childhood vaccinations.ConclusionSince the vaccine is offered for free in most of the European countries, the findings suggest that ethno-cultural and educational factors play an important role when it comes to HPVV uptake. Girls who were undervaccinated had also a lower uptake of standard childhood vaccines and mothers who were less likely to attend cervical cancer screening. This may indicate that only few parents have specific concerns with HPVV, and that preventive health care should seek ways to target these vulnerable groups.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Factors Associated With Vaccine Initiationmentioning

confidence: 86%

Section: Factors Associated With Vaccine Initiationmentioning

confidence: 99%

Section: Factors Associated With Vaccine Initiationmentioning

confidence: 99%

See 2 more Smart Citations

Determinants in the Uptake of the Human Papillomavirus Vaccine: A Systematic Review Based on European Studies

2015

View full text Add to dashboard Cite

show abstract

“…Second, girls with unknown vaccination status were considered non-vaccinated, which might underestimate vaccination coverage. Nevertheless, it is important to note that 2 French studies reported that the majority of HPV vaccine were done by GPs (82.84 to 92% of cases), 25,26 Third is the questionable ascertainment of eligibility for vaccination. Indeed, we compared eligibility estimated by the physician and eligibility based on the information about sexual activity found in the routine records of the medical doctors.…”

Section: Discussionmentioning

confidence: 99%

Human Papillomavirus vaccination in general practice in France, three years after the implementation of a targeted vaccine recommendation based on age and sexual history

Thierry

Lasserre

Rossignol

et al. 2015

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

In France, vaccination against human papilloma virus (HPV) was recommended in 2007 for all 14-year-old girls as well as "catch-up" vaccination for girls between 15-23 y of age either before or within one year of becoming sexually active. We evaluated the vaccine coverage according to the eligibility for vaccination in a sample of young girls aged 14 to 23 years, who were seen in general practices. A survey was proposed to 706 general practitioners (GPs) and carried out from July to September 2010. GPs, also called "family doctor," are physicians whose practice is not restricted to a specific field of medicine but instead covers a variety of medical problems in patients of all ages. Each participating GP included, retrospectively, the last female patient aged 14-17 y and the last female patient aged 18-23 y whom he had seen. A questionnaire collected information regarding the GP and the patients' characteristics. The vaccine coverage was determined according to the eligibility for vaccination, i.e. the coverage among younger women (14-17) and among those sexually active in the second age range (18-23). Sexual activity status was assessed by GP, according to information stated in the medical record. The 363 participating physicians (response rate 51.4%) included 712 patients (357 in the 14- to 17-year-old group and 355 in the 15- to 23-year-old group) in their responses. The rate of the vaccination coverage in the 14- to 17-year-old group was 55%. Among the girls in the 18- to 23-year-old group, 126 were eligible, and their vaccination coverage rate was 82%. The evaluation of the eligibility by the GPs was incorrect in 36% of the cases. Of the 712 patients, 6% of the girls had been vaccinated without a need for the vaccination, and 26% of the girls had not been vaccinated, although they needed to be vaccinated. Regarding the vaccine uptake, vaccination at the age of 14 was not as effective as vaccinating the older population for which vaccination was indicated as a catch-up program, based on sexual history. However, in more than one-third of the older population, difficulties remained regarding the determination of eligibility, according to the sexual history of the patient.

show abstract

Human Papillomavirus vaccine coverage among female students in Brunei Darussalam: results from the first 4 years of the national school-based vaccination programme

Chaw

Lim

Yussof

2019

Heliyon

View full text Add to dashboard Cite

BackgroundHuman Papillomavirus (HPV) is the leading cause of cervical cancer. HPV vaccination among girls (ages 9–14) is an effective way to prevent infection. Since 2012, Brunei Darussalam has implemented the National School-based HPV Vaccination programme which aims to vaccinate all female school students of 10–17 years old. This study was conducted to calculate and descriptively compare the coverage rates of all private and government secondary school students at both national and district levels, along with the parental consent rate.MethodsHPV vaccination records of all female students between January 2012 and December 2015 were retrospectively extracted from the School Health Services, Ministry of Health. Descriptive statistics were used to report the overall and annual vaccination coverage rate (by district, class year, nationality and type of school) and parental consent rate.ResultsA total of 27,178 female students were recorded during the study period, with an overall complete dose coverage rate of 85.8% (95% CI: 85.4%, 86.2%) and 90.8% (95% CI: 90.4%, 91.2%) for all and Bruneian female students, respectively. A similar trend could be observed each year, where there is a decrease in the coverage rate from the first, second and complete doses. Brunei-Muara had the lowest vaccination coverage and parental consent rates among the country's four districts. We also observed higher HPV vaccination coverage rate for government students. Parental consent rate of Bruneian students were considerably higher than that of non-Bruneian students.ConclusionOverall, the national school-based vaccination programme has achieved a high complete dose coverage rate in its first 4 years of implementation. Issues identified for this programme are vaccine cost and difficulty to reach students who have missed their scheduled vaccination in schools. The programme can be further improved by identifying other barriers of accepting and completing their HPV vaccine dose schedule.

show abstract

Human papillomavirus vaccines in Picardy, France: Coverage and correlation with socioeconomic factors

Abstract: Coverage and compliance rates of human papillomavirus vaccines in Picardy appear to be low. This study suggests that health authorities in Picardy should provide communication and action campaigns to improve these results.

Cited by 15 publications

References 20 publications

Determinants in the Uptake of the Human Papillomavirus Vaccine: A Systematic Review Based on European Studies

Determinants in the Uptake of the Human Papillomavirus Vaccine: A Systematic Review Based on European Studies

Human Papillomavirus vaccination in general practice in France, three years after the implementation of a targeted vaccine recommendation based on age and sexual history

Human Papillomavirus vaccine coverage among female students in Brunei Darussalam: results from the first 4 years of the national school-based vaccination programme

Contact Info

Product

Resources

About